Interscope, Inc.: Clinical Trials

5 trials sponsored by Interscope, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 enrolling by invitation, 1 terminated. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Enrolling by invitation 1, Terminated 1

Follow Interscope, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis
EndoRotor® System (Interscope, Inc., Northbridge, MA USA),, Conventional endoscopic devices (according to standards of care) - Acute Pancreatitis, Necrosis; Pancreas, Acute (Infectious)
Not applicableEnrolling by invitationErasmus Medical Center602022-09-022025-08-08
EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial
EndoRotor Therapy - Acute Pancreatic Necrosis, Acute Pancreatitis
Not applicableCompletedInterscope, Inc.302018-11-152021-11-02
EndoRotor® Endoscopic Mucosal Resection System for the Colon
EndoRotor Resection - Polyp of Colon, Endoscopic Mucosal Resection
Not applicableCompletedInterscope, Inc.662018-04-182022-04-05
Endorotor Resection In Refractory Barrett's Dysplasia Patients
EndoRotor Mucosal Resection System, Continued Ablation - Barrett's Esophagus With Dysplasia
Not applicableTerminatedInterscope, Inc.152018-02-092026-03-27
EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study
The EndoRotor® - Barretts Esophagus With Dysplasia
Not applicableCompletedFoundation for Liver Research302017-01-272020-01-29

Conditions studied

Pancreatitis (2)  ·  Colonic Polyps (1)  ·  Communicable Diseases (1)  ·  Necrosis (1)  ·  Pancreatitis, Acute Necrotizing (1)

Countries

United States (4)  ·  Germany (3)  ·  Netherlands (3)  ·  Italy (2)  ·  United Kingdom (2)  ·  Denmark (1)  ·  France (1)  ·  Sweden (1)

Top investigators

Marco Bruno, MD PhD (2)  ·  Arjun D. Koch, MD, PhD (1)  ·  Guido Costamagna, MD (1)  ·  Kenneth Wang, MD (1)

Results publications

PMID 34521118, PMID 34562471, PMID 38042207